相关实验视频

Updated: Jun 17, 2026

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

通过Dendrobium多糖体抑制视网膜新血管化:一篇综述

Dan Liu^1,2,3,4, Xingwang Chen^1,2,3,4, Shanjun Cai^1,2,3,4

¹Ophthalmology Department, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.

Frontiers in pharmacology

|July 15, 2025

概括

登德罗聚糖在治疗视网膜新血管化方面表现有前途,通过准多个途径. 需要进一步的研究来优化它们的结构和治疗用途.

科学领域:

眼科医生眼科眼科
药理学药理学是指药理学的学科.
自然产品化学化学

背景情况:

视网膜新血管化 (RNV) 是糖尿病视网膜病变等严重眼睛疾病的关键特征.
目前的治疗方法 (抗VEGF,激光疗法) 有局限性,包括耐药性和副作用.
对于RNV,需要新的,安全的和具有成本效益的疗法.

研究的目的:

审查Dendrobium多糖 (DP) 对视网膜新血管化的治疗潜力.
总结DP在治疗RNV中的结构,功能和机制.
识别眼科DP的研究缺口和未来方向.

主要方法:

系统审查关于Dendrobium多糖和视网膜新血管化的现有文献.
对DP对血管生成,炎症和氧化应激的影响的实验证据的分析.
评估DP对细胞外基质和肠道微生物群的影响.

主要成果:

登德罗比亚姆多糖类通过调节VEGF通路来抑制病理性血管生成.
DP显示与RNV相关的抗炎和抗氧化特性.
DP可能会逆转肠道失生症,可能会影响眼睛的健康.

结论:

菌体的多糖体代表了对RNV的有希望的多目标治疗候选者.
需要进一步的研究来澄清结构-活性关系,并优化DP用于临床应用.
交付系统的开发和对人体试验的验证是关键的下一步.

关键词:

这是一种抗炎药物.抗氧化剂是一种抗氧化剂.树突生物的多糖化物视网膜新血管化疗法血管内皮生长因子血管内皮生长因子

更多相关视频

Retinal Pathophysiological Evaluation in a Rat Model

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

相关概念视频

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...